Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.
Monday 9 February 2026
globalnews.ca - 5 days ago
Novo Nordisk says Canada will hit semaglutide sales as patents expire
Windscribe CEO Says ‘No User Data’ at Risk After Dutch Authorities Reportedly Seize Server
- cnet.com
I Just Learned You Can Subscribe To Dyson Stylers From £6.24 A Month, And I m Sprinting To The Checkout
- huffingtonpost
Starmer s Premiership Is Hanging By A Thread Over The Mandelson Scandal. How Did We Get Here?
- huffingtonpost
2026 Winter Olympics Opening Ceremonies Performers: Mariah Carey, Andrea Bocelli and More
- nytimes.com
Trump Insists Putin Kept To His 7-Day Ceasefire Promise Despite Flurry Of Ukraine Attacks
- huffingtonpost